BioCardia, Inc. Operating Cash Flow
BioCardia, Inc. (BCDA) reported Operating Cash Flow of -$3.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- BioCardia, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.74M.
- BioCardia, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.66M.
- BioCardia, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.50M.
- BioCardia, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.67M.
- BioCardia, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$7.44M.
- BioCardia, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$7.89M.
- BioCardia, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$9.97M.
- BioCardia, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$10.56M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 15 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.39M 10-Q · filed 2026-08-12 | -$5.89M derived: sum of 3 quarters · filed 2026-08-12 | -$7.56M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | -$1.66M 10-Q · filed 2026-05-15 | -$4.16M derived: sum of 2 quarters · filed 2026-05-15 | -$5.83M derived: sum of 3 quarters · filed 2026-05-15 | -$7.48M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$4.17M derived: sum of 2 quarters · filed 2026-03-24 | -$5.82M derived: sum of 3 quarters · filed 2026-08-12 | -$7.44M 10-K · filed 2026-03-24 | |||
| 2025-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.32M derived: sum of 2 quarters · filed 2026-08-12 | -$4.94M 10-Q · filed 2025-11-12 | -$7.37M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.27M 10-Q · filed 2026-08-12 | -$5.70M derived: sum of 3 quarters · filed 2026-08-12 | -$8.31M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$1.62M 10-Q · filed 2026-05-15 | -$4.05M derived: sum of 2 quarters · filed 2026-05-15 | -$6.66M derived: sum of 3 quarters · filed 2026-05-15 | -$7.97M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$5.04M derived: sum of 2 quarters · filed 2026-03-24 | -$6.36M derived: sum of 3 quarters · filed 2026-03-24 | -$7.89M 10-K · filed 2026-03-24 | -$8.03M 10-K · filed 2025-03-26 | ||
| 2024-09-30 | -$2.61M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-12 | -$3.92M derived: sum of 2 quarters · filed 2025-11-12 | -$5.45M 10-Q · filed 2025-11-12 | -$7.30M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$1.31M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-10-29 | -$2.84M 10-Q/A · filed 2025-10-29 | -$4.69M derived: sum of 3 quarters · filed 2025-10-29 | -$7.11M derived: sum of 4 quarters · filed 2025-10-29 | |||
| 2024-03-31 | -$1.53M 10-Q · filed 2025-05-14 | -$3.38M derived: sum of 2 quarters · filed 2025-05-14 | -$5.79M derived: sum of 3 quarters · filed 2025-05-14 | -$8.94M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$4.26M derived: sum of 2 quarters · filed 2025-03-26 | -$7.41M derived: sum of 3 quarters · filed 2025-03-26 | -$9.97M 10-K · filed 2025-03-26 | |||
| 2023-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$5.56M derived: sum of 2 quarters · filed 2024-11-13 | -$8.12M 10-Q · filed 2024-11-13 | -$11.12M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$5.71M 10-Q · filed 2024-08-13 | -$8.71M derived: sum of 3 quarters · filed 2024-08-13 | -$10.71M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$2.56M 10-Q · filed 2024-05-14 | -$5.56M derived: sum of 2 quarters · filed 2024-05-14 | -$7.56M derived: sum of 3 quarters · filed 2024-05-14 | -$10.21M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$5.00M derived: sum of 2 quarters · filed 2024-03-27 | -$7.65M derived: sum of 3 quarters · filed 2024-03-27 | -$10.56M 10-K · filed 2024-03-27 | |||
| 2022-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.65M derived: sum of 2 quarters · filed 2023-11-08 | -$7.56M 10-Q · filed 2023-11-08 | -$10.54M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$5.56M 10-Q · filed 2023-08-09 | -$8.53M derived: sum of 3 quarters · filed 2023-08-09 | -$11.18M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$2.91M 10-Q · filed 2023-05-10 | -$5.89M derived: sum of 2 quarters · filed 2023-05-10 | -$8.53M derived: sum of 3 quarters · filed 2023-05-10 | -$11.40M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$5.62M derived: sum of 2 quarters · filed 2023-03-29 | -$8.48M derived: sum of 3 quarters · filed 2023-03-29 | -$10.37M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$5.51M derived: sum of 2 quarters · filed 2022-11-09 | -$7.39M 10-Q · filed 2022-11-09 | -$10.81M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$4.75M 10-Q · filed 2022-08-10 | -$8.16M derived: sum of 3 quarters · filed 2022-08-10 | -$11.77M derived: sum of 4 quarters · filed 2022-08-10 | |||
| 2021-03-31 | -$1.88M 10-Q · filed 2022-05-11 | -$5.30M derived: sum of 2 quarters · filed 2022-05-11 | -$8.90M derived: sum of 3 quarters · filed 2022-05-11 | -$11.25M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$7.02M derived: sum of 2 quarters · filed 2022-03-29 | -$9.36M derived: sum of 3 quarters · filed 2022-03-29 | -$12.36M 10-K · filed 2022-03-29 | |||
| 2020-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$5.95M derived: sum of 2 quarters · filed 2021-11-10 | -$8.94M 10-Q · filed 2021-11-10 | -$12.20M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$5.34M 10-Q · filed 2021-08-12 | -$8.59M derived: sum of 3 quarters · filed 2021-08-12 | -$10.06M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$2.99M 10-Q · filed 2021-05-13 | -$6.25M derived: sum of 2 quarters · filed 2021-05-13 | -$7.72M derived: sum of 3 quarters · filed 2021-05-13 | -$9.97M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$4.73M derived: sum of 2 quarters · filed 2021-03-30 | -$6.98M derived: sum of 3 quarters · filed 2021-03-30 | -$9.45M 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$3.72M derived: sum of 2 quarters · filed 2020-11-10 | -$6.19M 10-Q · filed 2020-11-10 | -$9.44M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$4.72M 10-Q · filed 2020-08-13 | -$7.96M derived: sum of 3 quarters · filed 2020-08-13 | -$9.97M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$2.46M 10-Q · filed 2020-05-15 | -$5.71M derived: sum of 2 quarters · filed 2020-05-15 | -$7.72M derived: sum of 3 quarters · filed 2020-05-15 | -$10.50M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | -$3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | -$5.25M derived: sum of 2 quarters · filed 2020-04-09 | -$8.03M derived: sum of 3 quarters · filed 2020-04-09 | -$11.07M 10-K · filed 2020-04-09 | |||
| 2018-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | -$4.79M derived: sum of 2 quarters · filed 2019-11-19 | -$7.82M 10-Q · filed 2019-11-19 | -$10.35M derived: sum of 4 quarters · filed 2020-04-09 | |||
| 2018-06-30 | -$2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$5.81M 10-Q · filed 2019-08-14 | -$8.34M derived: sum of 3 quarters · filed 2020-04-09 | -$10.12M derived: sum of 4 quarters · filed 2020-04-09 | |||
| 2018-03-31 | -$3.04M 10-Q · filed 2019-05-15 | -$5.56M derived: sum of 2 quarters · filed 2020-04-09 | -$7.34M derived: sum of 3 quarters · filed 2020-04-09 | -$9.43M derived: sum of 4 quarters · filed 2020-04-09 | |||
| 2017-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | -$4.30M derived: sum of 2 quarters · filed 2020-04-09 | -$6.39M derived: sum of 3 quarters · filed 2020-04-09 | -$8.67M 10-K · filed 2020-04-09 | |||
| 2017-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$3.87M derived: sum of 2 quarters · filed 2018-11-08 | -$6.15M 10-Q · filed 2018-11-08 | -$8.66M derived: sum of 4 quarters · filed 2019-04-02 | |||
| 2017-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$4.37M 10-Q · filed 2018-08-09 | -$6.88M derived: sum of 3 quarters · filed 2019-04-02 | ||||
| 2017-03-31 | -$2.28M 10-Q · filed 2018-05-10 | -$4.79M derived: sum of 2 quarters · filed 2019-04-02 | |||||
| 2016-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | -$5.52M 10-K · filed 2019-04-02 | |||||
| 2016-09-30 | -$3.01M 10-Q · filed 2017-11-09 | ||||||
| 2015-12-31 | -$7.02M 10-K · filed 2018-03-16 | ||||||
| 2014-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $106.00K 10-Q · filed 2014-08-06 | $138.00K derived: sum of 3 quarters · filed 2014-08-06 | $132.00K derived: sum of 4 quarters · filed 2014-08-06 | |||
| 2014-03-31 | $27.00K 10-Q · filed 2014-05-12 | $59.00K derived: sum of 2 quarters · filed 2014-05-12 | $53.00K derived: sum of 3 quarters · filed 2014-05-12 | $68.00K derived: sum of 4 quarters · filed 2014-08-06 | $54.00K 10-Q · filed 2014-05-12 | ||
| 2013-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $26.00K derived: sum of 2 quarters · filed 2014-03-24 | $41.00K derived: sum of 3 quarters · filed 2014-08-06 | $27.00K 10-K · filed 2014-03-24 | |||
| 2013-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $9.00K derived: sum of 2 quarters · filed 2014-08-06 | -$5.00K 10-Q · filed 2013-11-01 | $440.00K derived: sum of 4 quarters · filed 2014-08-06 | |||
| 2013-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $1.00K 10-Q · filed 2014-08-06 | $446.00K derived: sum of 3 quarters · filed 2014-08-06 | $385.00K derived: sum of 4 quarters · filed 2014-08-06 | |||
| 2013-03-31 | -$14.00K 10-Q · filed 2014-05-12 | $431.00K derived: sum of 2 quarters · filed 2014-05-12 | $370.00K derived: sum of 3 quarters · filed 2014-05-12 | -$298.00K derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $384.00K derived: sum of 2 quarters · filed 2014-03-24 | -$284.00K derived: sum of 3 quarters · filed 2014-03-24 | -$310.00K 10-K · filed 2014-03-24 | |||
| 2012-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$729.00K derived: sum of 2 quarters · filed 2013-11-01 | -$755.00K 10-Q · filed 2013-11-01 | -$1.56M derived: sum of 4 quarters · filed 2013-11-01 | |||
| 2012-06-30 | -$668.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$694.00K 10-Q · filed 2013-07-26 | -$1.50M derived: sum of 3 quarters · filed 2013-07-26 | -$1.42M derived: sum of 4 quarters · filed 2013-07-26 | |||
| 2012-03-31 | -$26.00K 10-Q · filed 2013-05-10 | -$835.00K derived: sum of 2 quarters · filed 2013-05-10 | -$748.00K derived: sum of 3 quarters · filed 2013-05-10 | -$2.56M derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | -$809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$722.00K derived: sum of 2 quarters · filed 2013-03-22 | -$2.53M derived: sum of 3 quarters · filed 2013-03-22 | -$3.09M 10-K · filed 2013-03-22 | |||
| 2011-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$1.72M derived: sum of 2 quarters · filed 2012-11-08 | -$2.28M 10-Q · filed 2012-11-08 | -$2.85M derived: sum of 4 quarters · filed 2012-11-08 | |||
| 2011-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$2.37M 10-Q · filed 2012-08-10 | -$2.92M 10-Q · filed 2011-08-11 | -$2.94M derived: sum of 3 quarters · filed 2012-08-10 | -$4.05M derived: sum of 4 quarters · filed 2012-08-10 | ||
| 2011-03-31 | -$558.00K 10-Q · filed 2012-05-15 | -$1.13M derived: sum of 2 quarters · filed 2012-05-15 | -$2.24M derived: sum of 3 quarters · filed 2012-05-15 | ||||
| 2010-12-31 | -$570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$1.68M derived: sum of 2 quarters · filed 2012-03-29 | -$4.28M 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-15 | -$3.71M 10-Q · filed 2011-11-15 | |||||
| 2010-06-30 | -$2.59M 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |